 Astellas Pharma Inc OTC: ALPMF and Sutro Biopharma Inc NASDAQ: STRO announced a strategic collaboration and licensing agreement focused on the discovery and development of immunostimulatory antibody-drug conjugates iADC. iADCs are a next-generation. 